Pharma Pulse 10/16/24: Balancing Personalized Marketing and Maintaining Data Privacy, Is PBM Reform Nearing the Finish Line? & more

Balancing Personalized Marketing and Maintaining Data Privacy

In this part of her video interview, Amanda Powers-Han, Chief Marketing Officer, Greater Than One and Pharmaceutical Executive Advisory Board Member discusses how pharmaceutical companies can effectively balance personalized marketing efforts with maintaining data privacy and ensuring patient trust.

Is PBM Reform Nearing the Finish Line?

For the past 15 years or so, independent pharmacy has been pushing consistently for transparency into the business practices of pharmacy benefit managers (PBMs) and reforms to their tactics. Patient steering, spread pricing, take-it-or-leave-it contracts, formulary manipulations, low or below-cost reimbursements, and other schemes have put tremendous pressure on independent pharmacies and patients seeking affordable, accessible care.

Amazon, Databricks Strike Five-Year Deal Around AI Chips

Databricks will tap Amazon’s Trainium chips to power services for building AI systems, a move that could cut costs for businesses.

AllazoHealth Appoints Three New Advisory Board Members Amid Product Expansions

AllazoHealth, the pioneer in driving therapy initiation, adherence, and health outcomes with artificial intelligence (AI)-powered personalization, today announced that Joy S. Neely, Nagaraja Srivatsan, and Kenneth Ziegler have joined its advisory board. The three executives have extensive backgrounds in life sciences, technology, and enterprise growth strategies, and will provide valuable insights to AllazoHealth as the company initiates plans for product expansions and growth.

Nicholas Saraceno on LinkedIn

Had the chance to sit in on a session at #AccessInsights centered around mapping out the third, fourth, and fifth moves on the chessboard when it comes to healthcare policy interpretation. Shoutout to IntegriChain's Jeffrey Baab for insight as to how various market events, landmark policy decisions, and stakeholder reactions are affecting how regulators, plan sponsors, payers, distributors, influencers, dispensers/sites of care, and service providers will continue to evolve and react. Pharmaceutical Commerce Magazine

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs